Literature DB >> 7599636

Characterisation of molecular defects in X-linked amelogenesis imperfecta (AIH1).

N J Lench1, G B Winter.   

Abstract

Amelogenins are an heterogenous family of proteins produced by ameloblasts of the enamel organ during tooth development. Disturbances of enamel formation occur in amelogenesis imperfecta, a clinically heterogenous group of inherited disorders characterised by defective enamel biomineralisation. An amelogenin gene, AMGX, has been mapped to the short of the X chromosome (Xp22.1-p22.3) and has been implicated in the molecular pathology of X-linked amelogenesis imperfecta (AIH1). We have identified three families exhibiting AIH1 and screened the AMGX gene for mutations using single-strand conformational polymorphism analysis and DNA sequencing. Three novel mutations were identified: a C-T substitution in exon 5, and a G-T substitution and single cytosine deletion in exon 6, confirming the existence of extensive allelic heterogeneity in this condition. The identification of family-specific mutations will enable early identification of affected individuals and correlation of clinical phenotype with genotype will facilitate an objective system of disease classification.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599636     DOI: 10.1002/humu.1380050310

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  21 in total

1.  Perturbed amelogenin secondary structure leads to uncontrolled aggregation in amelogenesis imperfecta mutant proteins.

Authors:  Rajamani Lakshminarayanan; Keith M Bromley; Ya-Ping Lei; Malcolm L Snead; Janet Moradian-Oldak
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

2.  Molecular evolution of amelogenin in mammals.

Authors:  Sidney Delgado; Marc Girondot; Jean-Yves Sire
Journal:  J Mol Evol       Date:  2005-01       Impact factor: 2.395

3.  Folding, assembly, and aggregation of recombinant murine amelogenins with T21I and P41T point mutations.

Authors:  Keith M Bromley; Rajamani Lakshminarayanan; Ya-Ping Lei; Malcolm L Snead; Janet Moradian-Oldak
Journal:  Cells Tissues Organs       Date:  2011-05-02       Impact factor: 2.481

4.  Vectorette PCR isolation of microsatellite repeat sequences using anchored dinucleotide repeat primers.

Authors:  N J Lench; A Norris; A Bailey; A Booth; A F Markham
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

5.  The energetic basis for hydroxyapatite mineralization by amelogenin variants provides insights into the origin of amelogenesis imperfecta.

Authors:  Jinhui Tao; Yongsoon Shin; Rajith Jayasinha; Garry W Buchko; Sarah D Burton; Alice C Dohnalkova; Zheming Wang; Wendy J Shaw; Barbara J Tarasevich
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-25       Impact factor: 11.205

6.  A large interstitial deletion encompassing the amelogenin gene on the short arm of the Y chromosome.

Authors:  Wanda Lattanzi; Marilena C Di Giacomo; Gennaro M Lenato; Guglielmina Chimienti; Gianfranco Voglino; Nicoletta Resta; Gabriella Pepe; Ginevra Guanti
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

7.  Target gene analyses of 39 amelogenesis imperfecta kindreds.

Authors:  Hui-Chen Chan; Ninna M R P Estrella; Rachel N Milkovich; Jung-Wook Kim; James P Simmer; Jan C-C Hu
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

Review 8.  The molecular etiologies and associated phenotypes of amelogenesis imperfecta.

Authors:  J Timothy Wright
Journal:  Am J Med Genet A       Date:  2006-12-01       Impact factor: 2.802

Review 9.  Molecular genetics of ameloblast cell lineage.

Authors:  Marianna Bei
Journal:  J Exp Zool B Mol Dev Evol       Date:  2009-07-15       Impact factor: 2.656

10.  Controls of nature: Secondary, tertiary, and quaternary structure of the enamel protein amelogenin in solution and on hydroxyapatite.

Authors:  Wendy J Shaw; Barbara J Tarasevich; Garry W Buchko; Rajith M J Arachchige; Sarah D Burton
Journal:  J Struct Biol       Date:  2020-09-24       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.